One woman spent years battling symptoms she couldn’t name—until a diagnosis and treatment finally brought clarity and renewed ...
Rula reports five common triggers of bipolar disorder: stress, sleep issues, seasonal changes, substance use, and hormonal ...
A longitudinal neuroimaging study comparing individuals with bipolar disorder and healthy participants found that bipolar ...
Add Yahoo as a preferred source to see more of our stories on Google. Inside of a digestive tract Precise changes in the connectivity between neurons caused by an imbalance of gut bacteria may help ...
Mental illness, particularly bipolar disorder, challenges the very notion of what we call reality. For those who live without it, reality feels stable and predictable. There is a baseline that holds ...
It's common for teenagers go through emotional ups and downs and do things that don't seem rational. Learn the two hallmark ...
Neither pain nor bipolar can be effectively treated in isolation; the treatments for one condition invariably affect the other, for better or worse. Thanks to a pancreatic tumor, major surgery, and ...
Diagnosing bipolar disorder can be difficult. While it is not hard to distinguish between its two characteristic phases—the high spirits of mania and the low spirits of depression—it is challenging to ...
A potential new treatment for bipolar disorder (BP) that significantly shortens treatment time has emerged, following a randomized clinical trial using accelerated intermittent theta burst stimulation ...
An accelerated schedule of intermittent theta burst transcranial magnetic stimulation (aiTBS) completed in less than a week is effective for treatment-resistant bipolar depression, the results of a ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Trisha Suppes, MD, ...
GH Research PLC (NASDAQ:GHRS) is among the best psychedelic stocks to buy in 2026. The company is advancing efforts to develop psychedelic medicines targeting conditions like depression, bipolar II ...